/
Navigation
C
Chronicles
Browse all articles
C
E
Explore
Semantic exploration
E
R
Research
Entity momentum
R
N
Nexus
Correlations & relationships
N
~
Story Arc
Topic evolution
S
Drift Map
Semantic trajectory animation
D
P
Posts
Analysis & commentary
P
Browse
@
Entities
Companies, people, products, technologies
Domains
Browse by publication source
Handles
Browse by social media handle
Detection
?
Concept Search
Semantic similarity search
!
High Impact Stories
Top coverage by position
+
Sentiment Analysis
Positive/negative coverage
*
Anomaly Detection
Unusual coverage patterns
Analysis
vs
Rivalry Report
Compare two entities head-to-head
/\
Semantic Pivots
Narrative discontinuities
!!
Crisis Response
Event recovery patterns
Connected
Nav: C E R N
Search: /
Command: ⌘K
Embeddings: large
VOICE ARCHIVE

@23andme

@23andme
5 posts
2025-06-14
23andMe announced a new definitive agreement to be acquired by TTAM Research Institute.  TTAM has committed to complying with the Company's privacy policy and all applicable law and to adopting additional consumer protections and privacy safeguards to enhance protections for customer data and privacy.  Read our press release here:
2025-06-14 View on X
Wall Street Journal

23andMe says TTAM Research Institute, a nonprofit backed by Anne Wojcicki, is the new buyer for the company's assets, offering $305M and topping Regeneron's bid

Wall Street Journal :

2025-05-20
We have reached a sale agreement with @Regeneron, a leading US-based biotechnology company, to carry forward 23andMe's mission and maintain customer privacy protections. Read more about today's announcement here: https://www.globenewswire.com/ ...
2025-05-20 View on X
Wall Street Journal

Regeneron Pharmaceuticals says it will acquire 23andMe's assets, including its Personal Genome Service, for $256M, set to close in Q3, in the bankruptcy auction

But What Happens to Your Data? David Braue / Information Age : Biotech buys bankrupt DNA data firm 23andMe for $400m Naomi Li Gan / Tech in Asia : Pharma giant Regeneron to buy gen...

2025-05-19
We have reached a sale agreement with @Regeneron, a leading US-based biotechnology company, to carry forward 23andMe's mission and maintain customer privacy protections. Read more about today's announcement here: https://www.globenewswire.com/ ...
2025-05-19 View on X
Wall Street Journal

Regeneron Pharmaceuticals says it will acquire 23andMe's assets, including its Personal Genome Service, for $256M, set to close in Q3, in the bankruptcy auction

Regeneron Pharmaceuticals said it will acquire substantially all of 23andMe's assets  —  Regeneron Pharmaceuticals …

2025-03-25
We believe in the strength of what we've built and believe today's announcement will enable 23andMe to emerge a more financially stable organization. We remain open for business, and there are no changes to the way we store, manage or protect customer data. For more details,
2025-03-25 View on X
Bloomberg

23andMe files for bankruptcy to “maximize the value of its business”, and co-founder and CEO Anne Wojcicki steps down; 23andMe was valued at $3.5B in June 2021

Most corporations are not going to look out for your privacy.  And we now have a federal government intent on using your data for bad purposes. Frank Figliuzzi / @frankfigliuzzi : ...

2025-03-24
We believe in the strength of what we've built and believe today's announcement will enable 23andMe to emerge a more financially stable organization. We remain open for business, and there are no changes to the way we store, manage or protect customer data. For more details,
2025-03-24 View on X
Bloomberg

23andMe files for bankruptcy to “maximize the value of its business”, and co-founder and CEO Anne Wojcicki steps down; 23andMe was valued at $3.5B in June 2021

The Silicon Valley-based firm will continue marketing itself to investors with the goal of getting at least …